Front. Oncol. Frontiers in Oncology Front. Oncol. 2234-943X Frontiers Media S.A. 10.3389/fonc.2023.1320477 Oncology Retraction Retraction: The oncolytic virus in cancer diagnosis and treatment Frontiers Editorial Office *

Approved by: Massimo Broggini, Mario Negri Institute for Pharmacological Research (IRCCS), Italy

*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

10 11 2023 2023 13 1320477 12 10 2023 12 10 2023 Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Retraction of the Review Article The oncolytic virus in cancer diagnosis and treatment by Cao G-D, He X-B, Sun Q, Chen S-H, Wan K, Xu X, Feng X-D, Li P-P, Chen B and Xiong M-M (2020) Front. Oncol. 10:1786. doi: 10.3389/fonc.2020.01786 section-in-acceptance Cancer Molecular Targets and Therapeutics

Following publication, concerns were raised regarding the scientific validity of the article. An investigation was conducted in accordance with Frontiers’ policies. It was found that these concerns were valid and that the article does not meet the standards of editorial and scientific soundness for Frontiers in Oncology; therefore, the article has been retracted.

This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors do not agree to this retraction.